Goodwin Procter LLP advised Evox Therapeutics on the deal. Evox Therapeutics, leading exosome therapeutics company, announced its £69.2 million Series C financing round. The financing was significantly...
Goodwin Procter LLP advised Evox Therapeutics on the deal. Evox Therapeutics, leading exosome therapeutics company, announced its £69.2 million Series C financing round. The financing was significantly...
You must be a Standard 1 Year member to access this content.